Compare LADR & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LADR | BLFS |
|---|---|---|
| Founded | 2008 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | 2014 | 1989 |
| Metric | LADR | BLFS |
|---|---|---|
| Price | $11.39 | $25.31 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | $12.75 | ★ $31.50 |
| AVG Volume (30 Days) | ★ 753.4K | 331.1K |
| Earning Date | 02-05-2026 | 11-06-2025 |
| Dividend Yield | ★ 8.06% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.63 | N/A |
| Revenue | ★ $233,492,000.00 | $100,144,000.00 |
| Revenue This Year | N/A | $20.67 |
| Revenue Next Year | $6.81 | $14.13 |
| P/E Ratio | $18.13 | ★ N/A |
| Revenue Growth | N/A | ★ 87.53 |
| 52 Week Low | $9.68 | $19.10 |
| 52 Week High | $11.92 | $29.62 |
| Indicator | LADR | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 64.01 | 49.43 |
| Support Level | $10.79 | $24.11 |
| Resistance Level | $11.48 | $25.98 |
| Average True Range (ATR) | 0.18 | 0.82 |
| MACD | 0.03 | 0.06 |
| Stochastic Oscillator | 84.06 | 67.51 |
Ladder Capital Corp is an internally-managed real estate investment trust that is in commercial real estate finance. The company originates and invests in a diverse portfolio of commercial real estate and real estate-related assets, focusing on senior secured assets. The company's investment activities include: (i) Primary business of originating senior first mortgage fixed and floating rate loans collateralized by commercial real estate with flexible loan structures; (ii) owning and operating commercial real estate, including net leased commercial properties; and (iii) investing in investment-grade securities secured by first mortgage loans on commercial real estate. The company has three reportable segments include loans: which derives maximum profit; securities; and real estate.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.